http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0001364-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7921dc8d5bda40d02d1c034c558fc71b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85b36b154baaf5d232c48330f484e2cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cf04b22d6668b9179dc040d1266b892
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_944ea0e267fca04783bff3d0b2f4f3b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2aa388e460f6cf478bd46c925c6ab10e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 1999-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dccb89a47ede8a2d9bd022446624a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66ccf0be519ecabf2f4a3b68466b8822
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d37ae57705c0399788d81e4e11dfb847
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5ba74943bbfb16c98301b7531653d01
publicationDate 2000-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0001364-A1
titleOfInvention Stable pharmaceutical compositions of thieno [3,2-c] pyridine derivatives
abstract A stable pharmaceutical composition of thieno [3,2-c] pyridine derivatives includes a water-soluble hydrophilic lubricant, namely polyethylene glycol, and at least one pharmaceutically acceptable excipient. A preferred thieno [3,2-c] pyridine derivative is ticlopidine or ticlopidine hydrochloride, which is useful for its anti-inflammatory, vasodilator and blood platelet aggregation inhibitor action. The pharmaceutical composition is free or substantially free of magnesium stearate, a water soluble polyvinlypyrrolidone and sodium starch glycollate.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-202006020892-U1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9144550-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1847259-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1310245-A1
priorityDate 1998-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4147787-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0829482-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0614659-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9809597-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4996058-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128610822
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6432616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12210218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412361

Total number of triples: 51.